Safety is based on the thorough screening and proper dosing of the medication and should be individualized for each person
The SNDS contains anonymized sociodemographic and medical data, including outpatient services, hospital discharges, drug dispensing, and causes of death
Triplehormone-receptor agonist retatrutide for obesity A phase 2 trial
Close coordination between your prescribing physician and a gastroenterologist can help ensure a safer, more comfortable experience
It acts through the GLP-1 receptor (GLP-1R), a G protein-coupled receptor predominantly expressed in pancreatic -cells, the gastrointestinal tract, and the central nervous system
Contrave may be preferred by patients with contraindications to GLP-1/GIP therapy, such as personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2